European Companies Search Engine

EU funding (€169,800): Exploring the Roles and Plasticity of T-Cell Responses in Anti-Bacterial Immunity Fts1 May 2013 Financial Transparency System

Overview

Text

Project

Subject of Grant or Contract EXPLORING THE ROLES AND PLASTICITY OF T-CELL RESPONSES IN ANTI-BACTERIAL IMMUNITY
Responsible Department REA - European Research Executive Agency
Programme Name 1.1.1 - Seventh Research framework programme (including sixth Research framework programme)
Type of Contract* Action Grant
Reference of the Legal Commitment (LC) SI2.162378
Management Type Direct management
Geographical Zone -
Budget BGUE
Action Location -
Commitment Total Amount (EUR) (A+B) 169,800.00
Project end Date 30/04/2015
Commitment Contracted Amount (EUR) (A) 169,800.00
Budget Line Name People
Funding Type Grant
Additional/Reduced Amount (EUR) (B) 0.00
Year 2013
Reference (Budget) CPM.330740-1033801.1
Commitment Consumed Amount (EUR) 169,800.00
Budget Line Number 15 07 77
Project Start Date 01/05/2013
Expense Type Operational

Beneficiaries

Coordinator Yes
Address RUE DE L INSTITUT 89
Beneficiary’s Contracted Amount (EUR) 169,800.00
Beneficiary’s Estimated Contracted Amount (EUR) 169,800.00
Postal Code 1330
Beneficiary Country Belgium
Beneficiary’s Estimated Consumed Amount (EUR) 169,800.00
VAT Number of Beneficiary BECrossroads Bank for Enterprises (KBO) 0440.872.918
Beneficiary Group Code LE05
Not-for-Profit Organisation (Nfpo) No
Beneficiary Type Private Companies
Name of Beneficiary GLAXOSMITHKLINE BIOLOGICALS SA*GSKBIO
NUTS2 Prov. Brabant Wallon
City RIXENSART
Non-Governmental Organisation (NGO) No

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Glaxo Smithkline Biologicals SA, Rixensart, Belgium.

Creative Commons License The visualizations for "Glaxosmithkline Biologicals SA - EU funding (€169,800): Exploring the Roles and Plasticity of T-Cell Responses in Anti-Bacterial Immunity" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.